These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 63805)

  • 41. New approaches to the classification of the lymphomata.
    Lukes RJ; Collins RD
    Br J Cancer Suppl; 1975 Mar; 2():1-28. PubMed ID: 1101914
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human malignant lymphomas in vitro. Characterization of biopsy cells and establishment of permanent cell lines.
    Sundström C; Nilsson K
    Acta Pathol Microbiol Scand A; 1978 Mar; 86(2):173-84. PubMed ID: 211794
    [TBL] [Abstract][Full Text] [Related]  

  • 43. T or B cell origin of some non-Hodgkin's lymphomas.
    Peter CR; MacKenzie MR; Glassy FJ
    Lancet; 1974 Sep; 2(7882):686-9. PubMed ID: 4142961
    [No Abstract]   [Full Text] [Related]  

  • 44. [Pathologicoanatomical characteristics of the most important forms of non-Hodgkin malignant lymphomas (based on the Kiel classification)].
    Shtern RD
    Arkh Patol; 1980; 42(11):71-80. PubMed ID: 7004413
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Monoclonal antibody studies in non-Hodgkin's lymphoma.
    Aisenberg AC; Wilkes BM; Harris NL
    Blood; 1983 Mar; 61(3):469-75. PubMed ID: 6824784
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Equine malignant lymphomas: morphologic and immunohistochemical classification.
    Kelley LC; Mahaffey EA
    Vet Pathol; 1998 Jul; 35(4):241-52. PubMed ID: 9684967
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Progress in the classification of lymphoid and/or monocytoid leukemias and of lympho and reticulosarcomas (non-Hodgkin's lymphomas).
    Mathé G; Belpomme D; Dantchev D; Pouillart P
    Biomedicine; 1975 May; 22(3):177-85. PubMed ID: 809067
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predictability of immunologic phenotype by morphologic criteria in diffuse aggressive non-Hodgkin's lymphomas.
    Jaffe ES; Strauchen JA; Berard CW
    Am J Clin Pathol; 1982 Jan; 77(1):46-9. PubMed ID: 7055097
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Correlations of immunologic markers with histologic features of human non-Hodgkin's lymphomas.
    Brubaker DB; Whiteside TL; Hartsock RJ
    Am J Clin Pathol; 1979 Jun; 71(6):651-64. PubMed ID: 377943
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Circulating monoclonal B lymphocytes in non-Hodgkin's lymphoma.
    Smith BR; Weinberg DS; Robert NJ; Towle M; Luther E; Pinkus GS; Ault KA
    N Engl J Med; 1984 Dec; 311(23):1476-81. PubMed ID: 6438505
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Canine malignant lymphomas: comparison of morphologic and immunologic parameters.
    Holmberg CA; Manning JS; Osburn BI
    J Natl Cancer Inst; 1976 Jan; 56(1):125-35. PubMed ID: 768497
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Classification of non-Hodgkin's lymphomas on the basis of Morphological and immunological features shared by normal and neoplastic lymphatic cells (author's transl)].
    Stein H
    Immun Infekt; 1976 Apr; 4(2):52-69. PubMed ID: 1085745
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Heterogeneity of neoplastic and reactive cell proliferation in non-Hodgkin's lymphomas linked to patient survival.
    Ffrench M; Magaud JP; Ffrench P; Berger F; Devaux Y; Duhaut P; Shen N; Coiffier B; Bryon PA
    Am J Clin Pathol; 1994 Apr; 101(4):413-20. PubMed ID: 8160629
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of T and B lymphocyte membrane markers in human non-Hodgkin malignant lymphomata.
    Brouet JC; Labaume S; Seligmann M
    Br J Cancer Suppl; 1975 Mar; 2():121-7. PubMed ID: 1081001
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Clinical relevance of the Kiel classification of non-Hodgkin's lymphomas (author's transl)].
    Stacher A; Heinz R; Waldner R; Böhnel J
    Wien Klin Wochenschr; 1980 Aug; 92(15):520-5. PubMed ID: 7001765
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reed-Sternberg-like cells in low-grade lymphomas are transformed neoplastic cells of B-cell lineage.
    Shin SS; Ben-Ezra J; Burke JS; Sheibani K; Rappaport H
    Am J Clin Pathol; 1993 Jun; 99(6):658-62. PubMed ID: 8322699
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Some problems on the histopathological diagnosis of non-Hodgkin's malignant lymphoma -- a proposal of a new type.
    Suchi T; Tajima K; Nanba K; Wakasa H; Mikata A; Kikuchi M; Mori S; Watanabe S; Mohri N; Shamoto M; Harigaya K; Itagaki T; Matsuda M; Kirino Y; Takagi K; Fukunaga S
    Acta Pathol Jpn; 1979 Sep; 29(5):755-76. PubMed ID: 386708
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunologic methods in cytology: definitive diagnosis of non-Hodgkin's lymphomas using immunologic markers for T- and B-cells.
    Martin SE; Zhang HZ; Magyarosy E; Jaffe ES; Hsu SM; Chu EW
    Am J Clin Pathol; 1984 Dec; 82(6):666-73. PubMed ID: 6391148
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Predictability of immunologic phenotype of malignant lymphomas by conventional morphology: a study of 60 cases.
    Frizzera G; Gajl-Peczalska KJ; Bloomfield CD; Kersey JH
    Cancer; 1979 Apr; 43(4):1216-24. PubMed ID: 376087
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Rappaport classification of non-Hodgkin's lymphomas: a closer look using other proposed classifications.
    Garvin AJ; Simon R; Young RC; DeVita VT; Berard CW
    Semin Oncol; 1980 Sep; 7(3):234-43. PubMed ID: 6998002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.